THORN RUN PARTNERS

Lobbying for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. · pharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Connecticut · House · Senate · $50,000.00 income · posted Jul 16, 2025

Lobbying activity 1

Health Issues

Policies related to creating incentives for innovation in the life sciences.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.